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Psoriasis is a common inflammatory skin condition
caused by genetic and environmental factors. Recent
genome-wide linkage analyses have identified a locus
encoding susceptibility to psoriasis and placed this
gene in the 12 cM interval between markers D6S426
and D6S276 on chromosome 6p21.3. This is a broad
region and encompasses the human major histo-
compatibility complex. We have sought to localize
the susceptibility gene more precisely by exploiting
the linkage, haplotype, and linkage disequilibrium
information available through genotyping 118
affected sib pairs, their parents and other affected
family members. A total of 14 highly polymorphic
markers were genotyped, combining anonymous loci
with the class I genes HLA-B and -C distributed across
a genetic interval of approximately 14 cM including
Psoriasis is a relapsing chronic inflammatory skin diseaseaffecting all racial groups with a peak prevalence of3% in northern European and Scandinavian caucasians(Lomholt, 1963; Camp, 1998). Phenotypic expressionis mainly confined to the skin, with well circumscribed
erythematous scaling plaques in a symmetrical distribution. Charac-
teristic features include epidermal keratinocyte hyperproliferation,
altered epidermal maturation, vascular proliferation, and inflam-
matory cell accumulation (Camp, 1998). Whereas the pathogenesis
of psoriasis remains uncertain, current evidence suggests a central
role for T lymphocytes in modulating the disease process (Barker,
1991).
Epidemiologic studies have implicated a genetic component to
psoriasis, including a monozygotic twin concordance rate of 70%
compared with a dizygotic twin concordance rate of 20% (Brandrup
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the entire major histocompatibility complex. Through
the application of higher density mapping within the
major histocompatibility complex, we identified those
regions most commonly shared identical by descent
in patients with psoriasis. Using the transmission–
disequilibrium test, we found significant evidence of
linkage and allelic association across an interval defined
by the markers tn62 (p J 1.0 H 10–7), HLA-B
(p J 4.0 H 10–7), and HLA-C (p 5 2.7 H 10–9), a
region encompassed within a 285 kb genomic DNA
fragment. Hence these studies contribute to the
refinement of the localization of a major psoriasis
susceptibility gene and place the critical region near
to HLA-C. Key words: human leukocyte antigen/linkage/
major histocompatibility complex. J Invest Dermatol 113:322–
328, 1999
et al, 1982), a 5–10-fold increased risk in first-degree relatives
(Theeuwes and Leder, 1993) and large multiple case pedigrees.
Previous case–control studies have demonstrated associations with
multiple major histocompatibility complex (MHC) class I and II
alleles. Interpretation of such studies, however, has been potentially
confounded by patient ascertainment bias, population stratification
effects, and reliance on serologically defined HLA typing. Genome-
wide linkage analyses have identified putative susceptibility loci on
chromosomes 1q, 2p, 4q, 6p, 8q, 16q, 17q, and 20p (Tomfohrde
et al, 1994; Matthews et al, 1996; Nair et al, 1997; Trembath et al,
1997; Capon et al, 1999). Recently, two genome wide linkage
scans (Nair et al, 1997; Trembath et al, 1997) and a region specific
analysis (Burden et al, 1998) have mapped a major locus for psoriasis
susceptibility to a 12 cM region at chromosome 6p21.3. As this
interval contains the 4 Mb MHC, these studies support prior case–
control studies in strongly suggesting that a MHC gene confers the
major genetic component to psoriasis.
The human MHC (HLA region) was first identified because it
contains genes encoding the major transplantation antigens. The
physiologic role for these cell surface molecules, the class I and II
antigens, were subsequently shown to be presentation of processed
antigen to T lymphocytes (Browning and McMichael, 1996). The
MHC is now known to contain over 100 other genes, some of
which play additional important parts in the immune response.
These observations are of particular interest because immune
mediators have been implicated in the pathogenesis of psoriasis
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Table I. Characteristics of the study cohorta
Affected relations and families Number
Total number of independent families 78
Total affected sibling pairs 118
2 siblings 54
3 siblings 14
4 siblings 2
5 siblings 1
2 parents available 83
1 parent available 25
0 parents available 10
Total affected relative pairs (non sib) 18
Total number of trios with both parents available 146
Total number of ‘‘trios’’ with one parent available 38
Number of fully independent trios 77
Total number of affected individuals 238
Total number of unaffected individuals 187
aIn the statistical analyses dependence of multiple affected sibling pairs was taken
into account as previously described (Satsangi et al, 1996).
(Barker, 1991). As the majority of MHC genes do not have
immune function, however, it remains possible that the MHC
encoded psoriasis susceptibility gene is not an immune system gene.
Linkage disequilibrium (LD) mapping offers an approach to
narrow the MHC candidate region (Spielman and Ewens, 1996).
When a mutation or polymorphism responsible for a specific disease
is first introduced into a population, it resides on a background
haplotype of linked markers in LD with one another. Recombina-
tion through many generations will tend to dissipate LD for all but
those markers in very close proximity to the disease locus. We
now describe the refinement of the MHC candidate region by
typing both microsatellite and HLA markers at intermediate density
in a British Caucasian psoriasis population. Using allele sharing and
family-based linkage disequilibrium analytical methods, we show
that a 285 kb region around markers tn62, HLA-B, and HLA-C
is most likely to contain the MHC-encoded psoriasis suscepti-
bility gene.
MATERIALS AND METHODS
Family ascertainment Individuals were studied from the caucasoid
cohort reported by Trembath et al (1997). In brief a total of 78 north
European families, ranging from nuclear pedigrees to extended kindreds,
all with a minimum of two affected members with psoriasis, were
investigated (Table I). A diagnosis of psoriasis was made using standard
clinical criteria (Camp, 1998). All affected and unaffected individuals were
assessed by one of two experienced dermatologists to ensure consistency
of application of diagnostic criteria. All probands had chronic plaque type
psoriasis and any doubtful cases were excluded. The population consisted
of 238 affected individuals, 45% male, 55% female, with a mean age of
onset of 16.1 y (range 1–59). Affected individuals were investigated for
both allele sharing and linkage disequilibrium. Genomic DNA was extracted
from peripheral blood by standard procedures and stored at –70°C until
genotyped. Ethical approval was obtained for this study.
Sequence-specific oligonucleotide probing HLA-B genotypes were
initially determined by sequence specific oligonucleotide typing as previ-
ously described (Yoshida et al, 1992). Briefly, four primers (supplied by
Oswel DNA Services, Southampton, U.K.) were used for locus-specific
amplification of all of exon 2 and all of exon 3. PCR reactions were
performed with 1600 ng DNA in an 80 µl reaction containing 8 µl 10 3
PCR buffer (Bioline, London, U.K.), 0.195 mM of each primer, 0.2 mM
of each dNTP, 2 mM of magnesium chloride, and 1.6 units of Taq
polymerase (Bioline). Polymerase chain reaction (PCR) amplification was
performed as follows: 96°C for 5 min; 96°C for 1 min, 65°C for 1 min,
72°C for 2 min, for 5 cycles; 96°C for 1 min, 55°C for 1 min, 72°C for
2 min, for 25 cycles; 72°C for 8 min (using a 9600 thermal cycler,
Perkin-Elmer, Warrington, U.K.). The PCR products were dot blotted,
cross-linked on to a nylon membrane and hybridized with 35 digoxigenin
labeled sequence-specific oligonucleotide probes (obtained from the British
Society for Histocompatibility and Immunogenetics). Following stringent
washing, detection was achieved using anti-digoxigenin alkaline phosphat-
ase Fab fragments (Boehringer Mannheim GmbH, Germany). HLA-C
typing was performed as previously described (Trembath et al, 1997). The
nomenclature used for genotyped alleles is the name of the locus followed
by an asterisk and the number of the allele (e.g., B*5701); the nomenclature
for serologic assignment is the name of the locus followed by the specificity
(e.g., B57).
Reference strand mediated conformational analysis Allele-specific
high resolution HLA-B genotyping was determined by reference strand
mediated conformational analysis (previously described as double strand
conformational analysis; Arguello et al, 1998). Briefly, fragments containing
exon 2, intron 2, and exon 3 of HLA-B were amplified with locus
specific primers. Labeled reference strands were prepared from homozygous
B-LCLs SP0010 (B*4402) and RSH (B*4201) using 59 fluorochrome Cy-
5 (Pharmacia Biotech, Uppsala, Sweden). Duplexes were formed by the
addition of 1 µl of labeled reference PCR product to 3 µl of sample PCR
product followed by denaturation at 95°C for 4 min; 55°C for 5 min and
addition of an aliquot of each marker mix (2 µl). Duplexes (2 µl) were
separated by electrophoresis for 530 min at 40°C through a nondenaturing
6% polyacrylamide gel (Long Ranger Gel Solution, JT Baker, Lichfield,
U.K.) in an ALFexpress automated sequencer (Pharmacia) at 30 W constant
power. The mobilities of each fluorescent duplex were analyzed using
Fragment Manager software (Pharmacia).
Microsatellite genotyping Genotyping was performed for 12 micro-
satellite polymorphic markers from chromosome 6p21.3. Oligonucleotide
primers for microsatellites lh1, d3a, f91, tn821, and tn62 (Lako et al, 1999)
were kindly provided by Dr R.D. Campbell and amplified as described by
Hsieh et al (1997). Other microsatellites were chosen form published
genetic maps (Reed et al, 1994; Dib et al, 1996; Martin et al, 1998). The
CEPH-Genethon map was used to establish intermarker distances for some
markers, and the rest were integrated using published physical distances
assuming 1 cM µ 1 Mb. The mean heterozygosity of markers was 75.1%.
Genotypes at each marker were determined using fluorescence labeled 59
primers and semiautomated techniques as described previously (Trembath
et al, 1997). Briefly, pooled amplified DNA was electrophoresed on 6%
acrylamide gels, which were run for 3 h at 900 V in an ABI 373A
automated sequencer (Perkin-Elmer). Semi-automated fragment sizing was
performed using GENESCAN 672 (version 2.1) software (Perkin-Elmer),
and genotyping carried out using GENOTYPER (version 2.0) software
(Perkin-Elmer). The microsatellite RING3CA was genotyped by radio-
nucleotide inclusion according to standard protocols. All genetic marker
data were maintained in the Cyrillic database system (Cherwell Scientific,
Oxford, U.K.).
Family haplotype analysis Haplotypes were constructed through the
application of the Cyrillic pedigree data program and by visual inspection,
assuming the minimum number of recombination events observed in each
family. If required to resolve apparent multiple recombination events,
markers were re-genotyped. All paternity issues had previously been
identified and excluded from the study. At each marker locus, an ancestral
allele was defined as that allele occurring in greatest excess frequency in
the affected cohort compared with the unaffected cohort. The assumed
ancestral haplotype, presumed to carry the disease mutation, was then
constructed using these alleles (Feder et al, 1996).
Statistical analysis Sib pair analysis, requiring no prior assumptions of
the mode of inheritance of susceptibility alleles in psoriasis, was performed
for the whole cohort using the SIBPAIR program (version 2.1) within the
ANALYZE package and as previously described (Trembath et al, 1997).
The transmission of alleles from heterozygous parents to affected offspring
was assessed by the use of the transmission-disequilibrium test (TDT) as
implemented in the program TDTLIKE (version 2.1), generating a TDT-
like likelihood ratio statistic, based on the algorithm by Terwilliger (1995).
Multipoint nonparametric analysis was performed using GENEHUNTER
version 1.1. in the nonparametric mode without partitioning for hetero-
geneity (Kruglyak et al, 1996). The program was configured for scoring of
all possible affected relative pairs (settings were skip large 5 off, analysis 5
nonparametric linkage, score 5 all, and increment 5 5).
RESULTS
Evidence for a psoriasis susceptibility gene located within
the interval between markers tn821 and HLA-C As psoriasis
is a multifactorial disease with an ambiguous mode of inheritance,
nonparametric methods of data analysis, which identify regions
of excess allele sharing compared with that under independent
assortment, have advantages over conventional parametric linkage
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Table II. Linkage results for the study cohort
Marker No. of alleles Heterozygosity SIBPAIR /ASPa linkage values NPLb score
observed in cohort
LOD p
D6S291 6 0.70 1.20 9.4 3 10–3 1.78
Ring3ca 10 0.77 2.86 1.4 3 10–4 1.88
lh1 13 0.71 3.15 7.0 3 10–5 2.51
d3a 13 0.76 2.07 1.0 3 10–3 2.75
f9n1 9 0.53 1.63 3.0 3 10–3 3.06
D6S273 8 0.75 2.45 3.9 3 10–4 3.28
tn821 13 0.81 3.42 3.6 3 10–5 3.29
TNFA 15 0.76 5.70 1.5 3 10–7 3.09
tn62 12 0.82 6.47 2.4 3 10–8 3.21
HLA B 40 c 6.16 5.0 3 10–8 2.94
HLA C 20 d 3.65 2.0 3 10–4 2.24
D6S265 8 0.78 2.17 9.9 3 10–5 2.19
D6S105 10 0.79 0.21 1.7 3 10–1 1.29
D6S276 14 0.83 1.84 1.25 3 10–3 1.48
aASP, affected sib pair.
bNPL, non parametric linkage values obtained from the GENEHUNTER analysis.
c223 B alleles defined to date.
d63 C alleles defined to date.
analysis. To determine the extent of allele sharing at chromosome
6p21.3, we genotyped 78 independent psoriatic families, containing
118 affected sib pairs and 18 non-sib relative pairs (Table I). We
analyzed a total of 14 markers (average intermarker distance 0.6 cM)
to maximize the information content for the region. LOD scores
suggestive of linkage (. 2.4) were maintained across the interval
flanked by D6S291 and D6S265 (7.5 cM centromeric to telomeric).
Within this interval, evidence of linkage was identified at marker
loci tn821 (LOD 5 3.42), TNFA (LOD 5 5.70), tn62 (LOD 5
6.47), HLA-B (LOD 5 6.16) and HLA-C (LOD 5 3.65). These
results are summarized in Table II.
Linkage of psoriasis to chromosome 6p21.3 was also demon-
strated by analysis of the genotype data with a nonparametric
multipoint method, GENEHUNTER, which supported excess
allele sharing for the region encompassed by d3a to HLA-B
(Fig 1) with a maximum nonparametric linkage value of 3.29
for the microsatellite number tn821. For the multipoint analysis
we based marker order on the Genethon map and where
necessary on known physical intervals, using sex averaged
recombination fractions as follows: tel-D6S276–1.0–D6S105–0.5–
D6S265–0.4–HLA-C-0.10–HLA-B–0.1–tn62–0.05–TNFA–0.05–
tn82–0.1–D6S273–0.1–f9n1–0.35–d3a–0.3–lh1–0.5–Ring3ca–
5.45–D6S291–cen.
Linkage disequilibrium (allelic association) analysis To
reduce the misleading effects of population stratification on asso-
ciation, non-transmitted parental genotypes were used as internal
controls in the TDT as a test of allelic association. For each locus,
the alleles with the most significant TDT values (using the
multiallelic statistic corrected for multiple allele testing) are repres-
ented in Table III. Ancestral alleles, as defined as the allele in
greatest excess in the patient group compared with the control
group, were D6S291–4, Ring3ca–3, lh1–8, d3a–5, f9n1–4,
D6S273–2, tn821–11, TNFA-4, tn62–3, HLA-B*5701, HLA-
Cw*0602, D6S265–2, D6S105–4, and D6S276–2. Alleles at
contiguous loci tn62, HLA-B, and HLA-C, encompassing an
µ 285 kb region, show the strongest linkage disequilibrium with
the disease phenotype, all at a significance level of p , 2 3 10–7
using the TDT test. Parent to offspring transmission of alleles HLA-
Cw*0602 and HLA-B*5701 occurred on 92 and 60 occasions,
respectively, compared with nontransmissions 28 and 16 times,
respectively. Immediately flanking markers on the centromeric side
of this peak also demonstrate significant allelic association (TNFA,
tn821, f9n1), but support for allelic association declines rapidly for
more telometric markers (D6S265, D6S105; see Fig 1). These data
strongly suggest the localization of the susceptibility locus to the
proximal part of the MHC in the 285 kb region flanked by markers
tn62 and HLA-C.
Haplotype analysis Using the marker order shown above,
haplotypes were constructed by inference from the genotypes of
the affected, the parents and other family members. Phase assignment
was such as to minimize the number of recombination events in
each family. Both chromosomes of all affected and unaffected
individuals were included in the construction of haplotype sets,
giving a total of 422, 130, and 194 chromosomes analyzed for
affected, unaffected sibs, and unaffected spouses, respectively. Within
these sets, the most common haplotypes are represented in Table IV.
In the affected individuals the most commonly occurring haplotype,
tn62–3, HLA-B*5701, HLA-Cw*0602, includes 91 chromosomes.
Although extending the haplotype reduces the total number of
chromosomes for the common haplotype, the more extended
haplotype f9n1–4, D6S273–5, tn821–11, TNFA-4, tn62–3, HLA-
B*5701, HLA-Cw*0602, D6S265–2 more closely resembles the
assumed ancestral haplotype. The ‘‘fractured’’ haplotypes are most
likely to reflect the effects of recombination, thereby reducing the
interval maintained under linkage disequilibrium. For the haplotype
f9n1–4, D6S273–5, tn821–11, TNFA-4, tn62–3, HLA-B*5701,
HLA-Cw*0602, D6S265–2, the most frequently occurring allele,
HLA-Cw*0602, was found in 37% of chromosomes in affected
individuals (typically in a heterozygous form) compared with
21% and 18% of chromosomes in unaffected sibs and spouses,
respectively. The only other haplotype at greater frequency in
the affected cohort also included HLA-Cw*0602. The extended
haplotype D6S273–2, tn821–4, TNFA-9, tn62–7, HLA-B*1302,
HLA-Cw*0602 occurred in 3%, 1.5%, and 1.3% of all chromosomes
in affected individuals, unaffected sibs, and unaffected spouses,
respectively. No other common haplotype was observed in the
affected group, even for those alleles with significant TDT values
as listed in Table III.
DISCUSSION
Recent studies of the cosegregation of psoriasis with genome-wide
markers by linkage analysis has revealed putative susceptibility loci
on chromosomes 1q, 2p, 4q, 6p, 8q, 16q, 17q, and 20p (Tomfohrde
et al, 1994; Matthews et al, 1996; Nair et al, 1997; Trembath et al,
1997; Capon et al, 1999). The most consistent and quantitatively
strongest locus conferring susceptibility to psoriasis, however, is
6p21.3, identified in two independent studies using large cohorts
of predominantly Caucasian origin (LOD scores . 3; Nair et al,
1997; Trembath et al, 1997) and confirmed by Burden et al (1998).
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Figure 1. Linkage and association results for the study cohort demonstrating a convergent peak at the boundary of the class III and class
I regions. The upper map illustrates genetic distances for the 14 markers used; the lower map physical relationships of known HLA genes in the area.
The 6p21.3 locus was estimated to contribute to greater than 35%
of overall familial risk (Trembath et al, 1997).
Genome-wide scans necessarily use markers spaced typically at
between 10 and 20 cM intervals. Hence our previous study was
only able to refine the disease loci to a minimum of a 10 cM
range. In this report we have used 14 highly informative poly-
morphic markers located within the MHC region to localize further
the psoriasis susceptibility disease locus. LOD scores significant for
linkage (LOD . 3.8) were obtained for three markers TNFA,
tn62, and HLA-B (p , 1.5 3 10–7, p , 2.4 3 10–8, p , 5 3
10–8, respectively) within a 250 kbp distance by SIBPAIR allele
sharing analysis. Further analysis of the data using GENEHUNTER
demonstrated excess allele sharing for a similar but broader region
encompassing these three markers. LD mapping, which performs
an association analysis minimizing the effects of population strati-
fication, demonstrated significant association for contiguous markers
tn62, HLA-B, and HLA-C over a 285 kb region using the TDT.
Thus, whereas GENEHUNTER identifies a maximum allele
sharing around markers tn82–1 to HLA-B, the TDT indicates the
susceptibility region is marginally telomeric to this, between markers
tn62 and HLA-C. Therefore, the chromosome 6p21.3 susceptibility
locus for psoriasis is likely to be within the interval defined by
tn62, HLA-B, and HLA-C, the marker loci exhibiting the most
significant allelic associations, at the boundary of the HLA class III
and class I regions.
The HLA-B and HLA-C loci, as well as other HLA loci,
have previously been associated with susceptibility to psoriasis in
numerous case–control studies (Russell et al, 1972; White et al,
1972; Svejgaard et al, 1974; Brenner et al, 1978; Tiwari and Terasaki,
1985). The most reproducible associations have been with the class
I alleles HLA-Cw6 and HLA-B57. The TDT data obtained in our
study have identified the same HLA risk alleles for a Caucasian
population. In addition, compared with case–control studies, which
usually compare disease populations with unrelated control popula-
tions, our study design reduced the potential confounding effects
of patient ascertainment bias, small study numbers and population
stratification. The use of family-based linkage disequilibrium map-
ping with internal controls has allowed the analysis of allelic
associations independent of population structure (Spielman et al,
1993; Schaid and Sommer, 1994; Thomson, 1995). Genotyping
rather than the traditional serologic assignment provided more
direct evidence that HLA-B*5701 and HLA-Cw*0602 are the
alleles strongly associated with psoriasis.
The use of family data in our study permitted the assignment of
marker allele phase and thus the unambiguous construction of
haplotypes for each individual. The most commonly shared MHC
regions ‘‘identical by descent’’ could then be determined. Haplotype
analysis demonstrated complete linkage disequilibrium between
HLA-B*5701 and HLA-Cw*0602 with no recombination observed
between either alleles in any family analyzed. The most common
haplotype observed in those affected was tn62–3, HLA-B*5701,
HLA-Cw*0602 (91 vs 13 p , 0.0001 sibs). A second haplotype
containing HLA-Cw*0602 was also noted more frequently in
affecteds than unaffecteds, however: tn62–7, HLA-B*1302, HLA-
Cw*0602 (23 vs 3 sibs p , 0.001). As HLA-Cw*0602 was the
single allele common to both haplotypes these findings would be
compatible with three possible explanations. First, that HLA-
Cw*0602 is the psoriasis disease susceptibility allele; secondly that
HLA-Cw*0602 is in strong linkage disequilibrium with the disease
allele. A third possibility is that neither HLA-B nor HLA-C are
the disease loci, but that both haplotypes HLA-B*5701-HLA-
Cw*0602 and HLA-B*1302-HLA-Cw*0602 define HLA regions
326 BALENDRAN ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Table III. Association results for the study cohorta
Marker Alleleb Allele sizec HRR (p value) Overall TDT (max likelihood Most significant alleles detected via the
estimate) (p value) multiallelic TDT
Allele Allele-specific p value
D6S291 4 207 2.2 3 10–3 9.7 3 10–2 4 4.90 3 10–2
3 05 3 2.86 3 102
Ring3ca 3 – 3.8 3 10–3 3.7 3 10–3 3 1.10 3 10–2
lh1 8 93 7.0 3 10–1 8.3 3 10–2 8 2.15 3 10–1
d3a 5 125 6.5 3 10–1 3.5 3 10–1 5 3.37 3 10–1
f9n1 4 98 2.1 3 10–3 6.8 3 10–5 4 2.29 3 104
6 102 6 3.30 3 101
D6S273 2 132 4.7 3 101 1.9 3 10–1 2 1.53 3 10–1
1 130 1 1.70 3 10–1
5 136 5 7.20 3 10–1
tn821 11 110 5.0 3 10–3 7.2 3 10–5 11 2.28 3 10–4
3 94 3 8.57 3 10–4
TNFA 4 104 5.6 3 10–3 2.0 3 10–3 4 8,52 3 10–3
7 110 7 7.28 3 10–1
tn62 3 152 2.0 3 10–6 1.0 3 10–7 3 5.07 3 10–7
7 160 7 2.37 3 10–1
HLA-B 5701 – 1.0 10–6 4.0 3 10–7 5701 3.08 3 10–6
5001 – 5001 8.97 3 10–2
HLA-C 0602 – 2.0 3 10–5 2.7 3 10–9 0602 2.07 3 10–8
1201,12021,12022 – 1201,12021,12022
D6S265 2 183 1.4 3 10–1 6.0 3 10–2 2 1.49 3 10–1
6 191 6 2.86 3 10–1
D6S105 4 153 6.2 3 10–1 1.9 3 10–1 2.86 3 10–1 4.73 3 10–1
6 157 6 8.94 3 10–1
D6S276 2 206 5.0 3 10–1 5.0 3 10–3 2 9.42 3 10–3
5 214 5 7.55 3 10–1
aThe most significant alleles at each locus detected via the multiallelic TDT linkage disequilibrium test (corrected for multiple testing; Spielman and Ewens, 1996) are shown.
bHLA-B and-C alleles are defined according to the XII Histocompatibility Workshop nomenclature (Bodmer et al, 1996); all other alleles are defined on the basis of their
mobility score (Reed et al, 1994).
cExpressed as mobility units on an ABI 373.
Table IV. Haplotypes associated with susceptibility to psoriasisa
(a)
f9n1 D6S273 tn821 TNFA tn62 HLA-B HLA-C D6S265 Affected (422 Unaffected sibs Unaffected spouses
chromosomes) (130 chromosomes) (194 chromosomes)
Cumulative Exclusive Cumulative Exclusive Cumulative Exclusive
haplotypes haplotypes haplotypes haplotypes haplotypes haplotypes
4 5 11 4 3 5701 0602 2 21 21 3 3 3 3
4 5 11 4 3 5701 0602 30 9 3 0 6 3
5 11 4 3 5701 0602 2 33 12 4 1 5 2
5 11 4 3 5701 0602 57 15 8 5 10 4
11 4 3 5701 0602 66 9 10 2 11 1
4 3 5701 0602 72 6 10 0 14 3
3 5701 0602 91 19 13 3 17 3
5701 0602 108 17 16 3 22 5
5701 125 17 16 0 24 2
0602 178 70 28 12 42 20
(b)
D6S273 tn821 TNFa tn62 HLA-B HLA-C Affecteds (422 Unaffected sibs Unaffected spouses
chromosomes) (130 chromosomes) (194 chromosomes)
Cumulative Exclusive Cumulative Exclusive Cumulative Exclusive
haplotypes haplotypes haplotypes haplotypes haplotypes haplotypes
2 4 9 7 1302 0602 15 2 3
4 9 7 1302 0602 16 1 2 0 3 0
9 7 1302 0602 17 1 2 0 4 1
7 1302 0602 23 6 3 1 5 1
1302 0602 25 2 3 0 7 2
0602 178 70 28 12 42 20
aAll unambiguous haplotypes occurring at greater frequency in affected than unaffected individuals are shown. Inferred haplotypes, where data for any of the markers was
missing, were excluded from the haplotype subtotals. The most extended haplotypes more closely resemble the ‘‘founder’’ haplotype. The shorter haplotypes reflect the effects
of recombination narrowing the region maintained under LD. Exclusive haplotypes represent chromosomes in which a shorter haplotype occurs and has not already been
represented within a larger haplotype.
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containing alleles at a number of loci which are required in
combination for disease predisposition.
In a previous case–control association study, Schmitt-Egenolf
et al (1996) demonstrated that the extended ancestral haplotype
EH57.1, which contains HLA-Cw6 and HLA-B57, conferred a
26-fold increased risk of developing psoriasis, a risk mainly conferred
by the class I portion of the haplotype. The relative risk for Cw6-
B57 was 26.7 compared with 2.8 for Cw6-B13. The authors
suggested that if HLA-C is the disease locus, HLA-B57 may act to
modify disease expression. Recently, Jenisch et al (1998) also
observed a high frequency of the same ancestral haplotype in
affected individuals from two large family cohorts. They similarly
found that in contrast to the class II region markers HLA-DR
and -DQ, the class I markers HLA-C and -B were retained
selectively among affected individuals four times more often than
among those unaffecteds. As they studied no markers in the 1 Mb
region between HLA-DQ and HLA-B, however, they were unable
to map the putative disease locus within this region. In contrast,
our study analyzed five markers in this region to refine the
susceptibility region to 285 kb around the class III/I region border.
HLA-B*5701 and HLA-Cw*0602 have also been associated
with psoriasis in Japanese, Indian, Chinese, Greek, and Jewish
populations (Economidou et al, 1985; Ozawa et al, 1988; Pitchappan
et al, 1989; Cao et al, 1993), suggesting the disease mutation is an
old mutation in tight linkage disequilibrium with HLA-B and -C.
Other disease associated alleles, however, such as HLA-Cw7,
have also been observed in these populations indicating different
haplotypes may be associated with disease in different racial groups.
Moreover, linkage disequilibrium between several HLA genes and
microsatellites has already been described with the existence of
numerous recognizable haplotypes (Foissac et al, 1997). Identifying
further polymorphic markers within this region and linkage dis-
equilibrium mapping of other ethnic populations with different
ancestral haplotypes may lead to better definition of the susceptibility
region. We are currently employing this approach in a number of
ethnic groups.
Many diseases have been associated with HLA genes, but only
a few have predominant class I or class III region associations,
including ankylosing spondylitis (HLA-B27) and Behc¸ets disease.
It has been suggested that MHC molecules contribute directly to
the development of class II associated diseases (such as IDDM) by
presenting altered antigen to CD41 T cells. HLA-B*5701 or
HLA-Cw*0602 could be similarly pathogenic in psoriasis through
presentation of antigen to CD81 T cells, but equally they may
simply be markers for a nearby gene. The identified region of
maximum association, the distal class III and proximal class I
regions, contain a variety of other genes important in immune
responsiveness, including tumor necrosis factor, lymphotoxin genes,
heat shock protein 70, and complement components. MICA and
MICB, HLA-like genes which are expressed in epithelial tissues,
have recently been strongly associated with Behc¸ets disease
(Groh et al, 1996; Zwirner et al, 1998). In addition, this region
includes many nonimmune genes, including some which may be
preferentially expressed in the skin. For example the S gene,
160 kbp telomeric to HLA-C, encodes a protein with sequence
homology to human keratin 10 (Zhou and Chaplin, 1993), although
a single small study has failed to provide evidence that it is associated
with susceptibility to psoriasis (Ishihara et al, 1996). We have begun
characterizing polymorphisms in genes within the candidate region
to identify DNA variants associated with psoriasis (Marshall et al,
1993; Wei et al, 1993; Goldsworthy et al, 1997). Establishing a
definite MHC locus should also aid in the partitioning of future
data, a mechanism likely to be required, in order to define genetic
heterogeneity and facilitate the localization of non-MHC loci
(Trembath et al, 1997).
In conclusion our results confirm both linkage and association
of psoriasis to HLA-B, HLA-C, and to the microsatellite marker
tn62, suggesting that the susceptibility gene is located in the 285 kb
region surrounding the boundary between the HLA class III and I
regions. Linkage disequilibrium analysis of other ethnic populations
with diverse haplotypes offers the promise of refining this region
further with the aim of identifying the 6p21.3 susceptibility locus
for psoriasis.
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